FMWA
Forvis Mazars Wealth Advisors Portfolio holdings
AUM
$4.64B
1-Year Return
13.39%
This Quarter Return
+3.1%
1 Year Return
+13.39%
3 Year Return
+51.65%
5 Year Return
+85.57%
10 Year Return
+162.49%
AUM
$1.23B
AUM Growth
+$28.7M
(+2.4%)
Cap. Flow
-$8.89M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
64.87%
Holding
269
New
13
Increased
64
Reduced
152
Closed
14
Top Buys
| 1 |
iShares US Treasury Bond ETF
GOVT
|
$10.3M |
| 2 |
SPDR Gold MiniShares Trust
GLDM
|
$10.1M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$5.01M |
| 4 |
Farmers & Merchants Bancorp
FMAO
|
$4.81M |
| 5 |
Vanguard Dividend Appreciation ETF
VIG
|
$1.76M |
Top Sells
| 1 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
$4.01M |
| 2 |
Stryker
SYK
|
$3.87M |
| 3 |
RTX Corp
RTX
|
$3.64M |
| 4 |
PepsiCo
PEP
|
$3.5M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
$2.98M |
Sector Composition
| 1 | Technology | 5.88% |
| 2 | Financials | 3.3% |
| 3 | Healthcare | 3% |
| 4 | Industrials | 2.38% |
| 5 | Consumer Staples | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares MSCI Emerging Markets ETF
EEM
$19B
| $734K | 0.06% |
17,095
-1,075
| -6% | -$46.2K |
|
127
Vanguard FTSE Developed Markets ETF
VEA
$170B
| $729K | 0.06% |
17,489
-2,766
| -14% | -$115K |
|
128
Bristol-Myers Squibb
BMY
$95B
| $706K | 0.06% |
15,557
-2,784
| -15% | -$126K |
|
129
iShares Core MSCI Emerging Markets ETF
IEMG
$102B
| $701K | 0.06% |
13,624
+2,001
| +17% | +$103K |
|
130
Vanguard Growth ETF
VUG
$187B
| $685K | 0.06% |
4,191
+54
| +1% | +$8.83K |
|
131
Amgen
AMGN
$151B
| $677K | 0.05% |
3,673
+98
| +3% | +$18.1K |
|
132
Vanguard Large-Cap ETF
VV
$44.7B
| $667K | 0.05% |
4,948
| – | – |
|
133
Broadcom
AVGO
$1.44T
| $666K | 0.05% |
23,150
+20
| +0.1% | +$575 |
|
134
QCR Holdings
QCRH
$1.34B
| $658K | 0.05% |
18,884
| – | – |
|
135
IBM
IBM
$230B
| $656K | 0.05% |
4,973
-436
| -8% | -$57.5K |
|
136
Abbott
ABT
$231B
| $653K | 0.05% |
7,762
-475
| -6% | -$40K |
|
137
Philip Morris
PM
$251B
| $647K | 0.05% |
8,241
-5,088
| -38% | -$399K |
|
138
AbbVie
ABBV
$376B
| $642K | 0.05% |
8,823
+243
| +3% | +$17.7K |
|
|
139
Stryker
SYK
$151B
| $638K | 0.05% |
3,105
-18,832
| -86% | -$3.87M |
|
140
Altria Group
MO
$112B
| $633K | 0.05% |
13,358
-403
| -3% | -$19.1K |
|
141
Schwab International Equity ETF
SCHF
$50.3B
| $624K | 0.05% |
38,896
+730
| +2% | +$11.7K |
|
142
DexCom
DXCM
$31.7B
| $622K | 0.05% |
16,596
+16
| +0.1% | +$600 |
|
143
Ford
F
$46.5B
| $618K | 0.05% |
60,458
+4,660
| +8% | +$47.6K |
|
144
iShares US Basic Materials ETF
IYM
$563M
| $598K | 0.05% |
6,298
-275
| -4% | -$26.1K |
|
145
Analog Devices
ADI
$121B
| $591K | 0.05% |
5,240
-633
| -11% | -$71.4K |
|
146
Kimberly-Clark
KMB
$42.9B
| $590K | 0.05% |
4,426
-538
| -11% | -$71.7K |
|
147
Vanguard Mid-Cap ETF
VO
$87.4B
| $590K | 0.05% |
3,532
-1,195
| -25% | -$200K |
|
148
CVS Health
CVS
$93.5B
| $586K | 0.05% |
10,755
-2,597
| -19% | -$142K |
|
149
Morgan Stanley
MS
$240B
| $585K | 0.05% |
13,350
-201
| -1% | -$8.81K |
|
150
Citigroup
C
$179B
| $576K | 0.05% |
8,228
-166
| -2% | -$11.6K |
|